Home > Healthcare > Biotechnology > Biotechnology R&D > DNA Synthesis Market
DNA Synthesis Market size was valued at USD 4 billion in 2023 and is projected to witness growth at a CAGR of 18.9% between 2024 and 2032. High market growth can be attributed to the advancements in synthetic biology and gene editing technologies such as CRISPR, coupled with growing adoption of precision medicine.
The growing emphasis on synthetic biology research is primarily driven by robust support for DNA synthesis initiatives, marked by substantial investments in R&D, alongside an expanding focus on DNA studies. For instance, in April 2023, NunaBio, a TechBio company specializing in synthetic DNA for research, secured USD 2.4 million in a seed round, supported by the Northeast Innovation Fund and the European Regional Development Fund.
The company is focused on innovating a groundbreaking approach to DNA synthesis, facilitating the efficient and cost-effective production of oligonucleotides on a large scale, with remarkable speed and precision. Thus, such growing research funding aimed to support and catalyze the development of technology, fosters the potential of synthetic biology across the genome sector, thereby propelling the market growth.
DNA synthesis is the process of artificially creating DNA molecules. It involves chemically synthesizing nucleotide sequences in the laboratory, that can be used for various applications such as genetic engineering, research, and biotechnology.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
DNA Synthesis Market Size in 2023: | USD 4 Billion |
Forecast Period: | 2024- 2032 |
Forecast Period 2024- 2032 CAGR: | 18.9% |
2032 Value Projection: | USD 19.2 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 225 |
Tables, Charts & Figures: | 389 |
Segments covered: | Service, Method, Application, End-use, & Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|